What is the optimal free testosterone level for a man undergoing testosterone replacement therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Optimal Free Testosterone Target on Replacement Therapy

The optimal free testosterone level for a man on testosterone replacement therapy should be in the mid-normal range, specifically targeting approximately 5-9 ng/dL (0.17-0.31 nmol/liter or 50-90 pg/mL) when measured by equilibrium dialysis or calculated from total testosterone and SHBG. 1

Treatment Target Framework

The Endocrine Society guidelines explicitly state that therapy should aim to raise serum testosterone level into the mid-normal range 1. This recommendation applies to both total and free testosterone measurements during monitoring.

Specific Free Testosterone Targets

For free testosterone specifically:

  • Lower limit of normal range: approximately 5-9 ng/dL (50-90 pg/mL) depending on the laboratory's reference population 1
  • Target zone: Mid-normal range, which translates to roughly 7-12 ng/dL (70-120 pg/mL) based on the reference ranges provided
  • Measurement method: Must use equilibrium dialysis or calculation from total testosterone and SHBG; analog immunoassays are inaccurate and not recommended 1, 2

Monitoring Algorithm

At 3-6 months after initiating therapy 1:

  1. Measure testosterone levels (timing depends on formulation):

    • Injectable testosterone: midway between injections
    • Transdermal gels: any time after 1 week of treatment
    • Transdermal patches: 3-12 hours after application
  2. Adjust dosing if:

    • Total testosterone >700 ng/dL (24.5 nmol/L) - reduce dose
    • Total testosterone <400 ng/dL (14.1 nmol/L) - increase dose
    • Free testosterone below mid-normal range - increase dose
  3. Continue annual monitoring thereafter

Important Clinical Caveats

Reference range variability is a major pitfall: Different laboratories report vastly different reference ranges for free testosterone, with lower limits ranging from 4-9 ng/dL (0.14-0.31 nmol/liter) 2, 1, 2. This 2-fold variation can lead to misdiagnosis and inappropriate treatment decisions 3.

Age considerations: The guidelines establish reference ranges based on healthy young men (typically 20-40 years old) 1. While some advocate for age-adjusted ranges, the Endocrine Society guidelines use young adult reference ranges as the standard for all ages receiving replacement therapy.

SHBG alterations matter: Free testosterone measurement becomes particularly important when SHBG is altered by:

  • Obesity (decreases SHBG)
  • Aging (increases SHBG)
  • Diabetes mellitus (decreases SHBG)
  • Thyroid disorders (hyper increases, hypo decreases SHBG)
  • Chronic illness 1

In these conditions, total testosterone alone may be misleading, and free testosterone provides a more accurate assessment of androgen exposure 1, 4.

Practical Implementation

Do not aim for supraphysiologic levels. The goal is restoration to normal physiologic range, not optimization to upper limits. Men with free testosterone levels maintained in the mid-normal range show:

  • Improved sexual function 5
  • Better mood and energy 5
  • Metabolic improvements 5
  • Acceptable safety profile regarding PSA and hematocrit 1

Avoid common errors:

  • Using analog free testosterone assays (inaccurate) 1
  • Targeting the upper limit of normal (increases adverse events)
  • Ignoring SHBG status when interpreting total testosterone
  • Failing to confirm levels are in mid-normal range at follow-up

The evidence consistently supports targeting the mid-normal physiologic range rather than attempting to achieve higher levels, as this approach balances efficacy with safety while avoiding the risks of supraphysiologic testosterone exposure 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.